$SYBX
SYNLOGIC, INC.

2018 Q2 Form 10-Q Financial Statement

#000156459018020755 Filed on August 09, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $254.0K $2.111M
YoY Change -87.97% 1801.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.730M $3.040M
YoY Change 55.59% 166.67%
% of Gross Profit
Research & Development $10.87M $8.532M
YoY Change 27.43% 131.72%
% of Gross Profit
Depreciation & Amortization $510.0K $13.00K
YoY Change 3823.08% -50.0%
% of Gross Profit
Operating Expenses $15.61M $11.57M
YoY Change 34.91% 127.63%
Operating Profit -$15.35M -$9.457M
YoY Change 62.33% 90.24%
Interest Expense $12.00K $7.000K
YoY Change 71.43% -107.78%
% of Operating Profit
Other Income/Expense, Net $761.0K -$10.00K
YoY Change -7710.0% -110.75%
Pretax Income -$14.59M -$9.390M
YoY Change 55.38% 321.08%
Income Tax
% Of Pretax Income
Net Earnings -$14.59M -$9.388M
YoY Change 55.42% 88.82%
Net Earnings / Revenue -5744.49% -444.72%
Basic Earnings Per Share
Diluted Earnings Per Share -$588.3K -$304.5K
COMMON SHARES
Basic Shares Outstanding 25.45M 20.86M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $144.3M $47.70M
YoY Change 202.53% -34.3%
Cash & Equivalents $27.72M $15.22M
Short-Term Investments $116.6M $32.50M
Other Short-Term Assets $2.100M $400.0K
YoY Change 425.0% -55.56%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $145.3M $48.11M
YoY Change 202.03% -34.55%
LONG-TERM ASSETS
Property, Plant & Equipment $14.60M $13.00K
YoY Change 112207.69% -98.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.200M $0.00
YoY Change -100.0%
Total Long-Term Assets $15.80M $13.00K
YoY Change 121438.46% -99.65%
TOTAL ASSETS
Total Short-Term Assets $145.3M $48.11M
Total Long-Term Assets $15.80M $13.00K
Total Assets $161.1M $48.12M
YoY Change 234.78% -37.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $47.00K
YoY Change 2240.43% -96.87%
Accrued Expenses $6.500M $1.400M
YoY Change 364.29% -36.36%
Deferred Revenue $179.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K
YoY Change
Total Short-Term Liabilities $8.200M $1.422M
YoY Change 476.65% -61.57%
LONG-TERM LIABILITIES
Long-Term Debt $300.0K $0.00
YoY Change
Other Long-Term Liabilities $7.900M
YoY Change
Total Long-Term Liabilities $8.200M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.200M $1.422M
Total Long-Term Liabilities $8.200M $0.00
Total Liabilities $16.50M $1.422M
YoY Change 1060.34% -61.57%
SHAREHOLDERS EQUITY
Retained Earnings -$17.00K
YoY Change
Common Stock $163.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $144.6M $46.70M
YoY Change
Total Liabilities & Shareholders Equity $161.1M $48.12M
YoY Change 234.78% -37.67%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$14.59M -$9.388M
YoY Change 55.42% 88.82%
Depreciation, Depletion And Amortization $510.0K $13.00K
YoY Change 3823.08% -50.0%
Cash From Operating Activities -$10.81M -$7.640M
YoY Change 41.49% 48.93%
INVESTING ACTIVITIES
Capital Expenditures -$990.0K -$290.0K
YoY Change 241.38% -29.27%
Acquisitions
YoY Change
Other Investing Activities -$17.58M $0.00
YoY Change -100.0%
Cash From Investing Activities -$18.56M -$290.0K
YoY Change 6300.0% -98.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $28.90M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.81M 40.61M
YoY Change -29.06% 406000.0%
NET CHANGE
Cash From Operating Activities -10.81M -7.640M
Cash From Investing Activities -18.56M -290.0K
Cash From Financing Activities 28.81M 40.61M
Net Change In Cash -560.0K 32.68M
YoY Change -101.71% -248.01%
FREE CASH FLOW
Cash From Operating Activities -$10.81M -$7.640M
Capital Expenditures -$990.0K -$290.0K
Free Cash Flow -$9.820M -$7.350M
YoY Change 33.61% 55.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
116585000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
28585000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
97000
CY2017Q2 us-gaap Interest Expense
InterestExpense
7000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-14591000
us-gaap Interest Expense
InterestExpense
15000
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.70
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.14
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24803379
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14555000
CY2017Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
81000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16831000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1232000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2017Q4 us-gaap Assets
Assets
99699000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2679000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4823000
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
179000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4734000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3036000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
444000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
668000
us-gaap Revenues
Revenues
608000
us-gaap Revenues
Revenues
2222000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10872000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8532000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19233000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13650000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
75000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-9388000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.20
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1997228
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22503802
us-gaap Operating Expenses
OperatingExpenses
27596000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1821736
CY2018Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
36000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-66000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9388000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25822000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16756000
us-gaap Depreciation
Depreciation
1192000
us-gaap Depreciation
Depreciation
454000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
us-gaap Share Based Compensation
ShareBasedCompensation
2413000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15352000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1262000
CY2018Q2 us-gaap Interest Expense
InterestExpense
12000
us-gaap Interest Expense
InterestExpense
26000
CY2018Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3000
CY2017Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
4000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
40697000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
82666000
us-gaap Proceeds From Issuance Of Preferred Limited Partners Units
ProceedsFromIssuanceOfPreferredLimitedPartnersUnits
26649000
us-gaap Share Based Compensation
ShareBasedCompensation
797000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1751000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
531000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
545000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-119000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1266000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1255000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-608000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-222000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
1095000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-127000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-169000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-189000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23835000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14540000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
114980000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
27445000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2892000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
419000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90427000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-419000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
217000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
113000
sybx Deferred Transaction Costs
DeferredTransactionCosts
34000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82449000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67199000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31813000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52240000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59537000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14636000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27724000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66876000
sybx Allowance For Tenant Improvements
AllowanceForTenantImprovements
1654000
sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilities
1447000
sybx Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilities
86000
us-gaap Interest Paid Net
InterestPaidNet
25000
us-gaap Interest Paid Net
InterestPaidNet
15000
sybx Assets Acquired Under Capital Leases
AssetsAcquiredUnderCapitalLeases
12000
sybx Equity Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
EquityIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
263000
sybx Adjustment To Transaction Costs For Amounts Included In Accounts Payable And Accrued Expenses
AdjustmentToTransactionCostsForAmountsIncludedInAccountsPayableAndAccruedExpenses
1051000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
805000
CY2017Q4 sybx Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
2027000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
143200000
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
us-gaap Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
The Company recognizes as an asset the incremental costs of obtaining a contract with a customer if the costs are expected to be recovered. As a practical expedient, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that we otherwise would have recognized is one year or less. To date, the Company has not incurred any incremental costs of obtaining a contract with a customer
CY2017Q3 us-gaap Business Acquisition Effective Date Of Acquisition1
BusinessAcquisitionEffectiveDateOfAcquisition1
2017-08-28
CY2017Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.14
CY2017Q3 sybx Common Stock Exchange Ratio
CommonStockExchangeRatio
0.5532
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16282496
CY2017Q3 sybx Number Of Members On Board Of Directors
NumberOfMembersOnBoardOfDirectors
7
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
116660000
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2018Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
81000
CY2018Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
116585000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
28593000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28585000
CY2018Q2 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
27
CY2017Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
7
CY2018Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0
CY2017Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0
CY2018Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
99000000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
19300000
CY2018Q2 sybx Other Than Temporary Impairment Losses Investments Number Available For Sale Securities
OtherThanTemporaryImpairmentLossesInvestmentsNumberAvailableForSaleSecurities
0
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
16377000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12898000
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1783000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3115000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1955000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1721000
CY2018Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
838000
CY2018Q2 sybx Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1846000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1909000
sybx Number Of Votes Entitled To Each Share Of Common Stock
NumberOfVotesEntitledToEachShareOfCommonStock
1
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
one-for-one
sybx Preferred Stock Conversion Percentage
PreferredStockConversionPercentage
1.00
sybx Share Based Compensation Arrangement By Share Based Payment Award Number Of Equity Plan Currently Active
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEquityPlanCurrentlyActive
2
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1494000
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
667000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1494000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
667000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2413000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
797000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
270000

Files In Submission

Name View Source Status
0001564590-18-020755-index-headers.html Edgar Link pending
0001564590-18-020755-index.html Edgar Link pending
0001564590-18-020755.txt Edgar Link pending
0001564590-18-020755-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sybx-10q_20180630.htm Edgar Link pending
sybx-20180630.xml Edgar Link completed
sybx-20180630.xsd Edgar Link pending
sybx-20180630_cal.xml Edgar Link unprocessable
sybx-20180630_def.xml Edgar Link unprocessable
sybx-20180630_lab.xml Edgar Link unprocessable
sybx-20180630_pre.xml Edgar Link unprocessable
sybx-ex101_100.htm Edgar Link pending
sybx-ex102_101.htm Edgar Link pending
sybx-ex311_6.htm Edgar Link pending
sybx-ex312_10.htm Edgar Link pending
sybx-ex321_8.htm Edgar Link pending
sybx-ex322_7.htm Edgar Link pending